Background/Objectives: The MAST kinases are ancient AGC kinases associated with many human diseases, such as cancer, diabetes, and neurodevelopmental disorders. We set out to describe the origins and diversification of MAST kinases from a structural and bioinformatic perspective to inform future research directions. Methods: We investigated MAST-lineage kinases using database and sequence analysis. We also estimate the functional consequences of disease point mutations on protein stability by integrating predictive algorithms and AlphaFold. Results: Higher-order organisms often have multiple MASTs and a single MASTL kinase. MAST proteins conserve an AGC kinase domain, a domain of unknown function 1908 (DUF), and a PDZ binding domain. D. discoideum contains MAST kinase-like proteins that exhibit a characteristic insertion within the T-loop but do not conserve DUF or PDZ domains. While the DUF domain is conserved in plants, the PDZ domain is not. The four mammalian MASTs demonstrate tissue expression heterogeneity by mRNA and protein. MAST1-4 are likely regulated by 14-3-3 proteins based on interactome data and in silico predictions. Comparative ΔΔG estimation identified that MAST1-L232P and G522E mutations are likely destabilizing. Conclusions: We conclude that MAST and MASTL kinases diverged from the primordial MAST, which likely operated in both biological niches. The number of MAST paralogs then expanded to the heterogeneous subfamily seen in mammals that are all likely regulated by 14-3-3 protein interaction. The reported pathogenic mutations in MASTs primarily represent alterations to post-translational modification topology in the DUF and kinase domains. Our report outlines a computational basis for future work in MAST kinase regulation and drug discovery.
Breast cancer is the most commonly diagnosed malignancy and a leading cause of cancer-related mortality. Hormone receptor-positive (HR+) tumors represent the most prevalent metastatic subtype, and early dissemination remains a major clinical challenge. Commensal dysbiosis, defined as an inflammatory gut microbiome with low biodiversity, promotes metastasis by inducing mammary gland inflammation. Here, we investigated systemic mechanisms governing dysbiosis-induced metastasis. Metabolomic profiling revealed elevated primary bile acids (BAs) in the dysbiotic fecal microbiome. Sequestration and supplementation approaches demonstrated that, beyond driving metabolic disease and mammary gland inflammation, primary BAs orchestrated enhanced HR+ tumor dissemination via a prostaglandin E2 (PGE2)-dependent pathway. Analysis of The Cancer Genome Atlas (TCGA) showed that BA, insulin resistance, and PGE2 gene signatures associated with reduced survival in patients with HR+ tumors. In complementary analyses using the Epic Cosmos electronic health record database, bile acid sequestrant use was associated with longer restricted mean survival time among patients with metastatic disease. Together, these findings reveal that commensal dysbiosis-associated loss of microbial BA metabolism elevates primary BAs and promotes HR+ metastatic progression through PGE2 signaling.
Adenosine is a widely distributed signaling molecule whose levels rise during conditions of metabolic stress, hypoxia, or inflammation. Adenosine is a homeostatic regulator of neuronal, cardiovascular, immune, and metabolic functions through activation of adenosine receptors. Here, we show that administration of adenosine rapidly elicits an immediate and pronounced excursion of glucose and non-esterified fatty acids (NEFA) in mice refed for four hours but is greatly attenuated in fasted mice. This adenosine-mediated postprandial response suggests that adenosine is a potent regulator of postprandial nutrient handling. Selective agonists and antagonists of A2A and A2B adenosine receptors demonstrate that activation of either is sufficient to evoke adenosine’s metabolic response, but both receptors must be inhibited simultaneously to abolish it. Adenosine strongly stimulates hepatic glucose production and adipose lipolysis, and this catabolic activity depends on sympathetic nerve activity as it requires autonomic signal transmission and is inhibited by blocking adrenergic receptors. Genetic ablation studies identify A2A and A2B receptors expressed on neurons, likely central neurons, as the primary site of action for mediating adenosine’s effects on whole-body metabolism. Collectively, these data demonstrate that acute adenosine administration promotes centrally mediated metabolic effects, particularly during the postprandial period. Rigorous dissection of signaling pathways shows that A2A and A2B receptors are individually sufficient and collectively necessary for adenosine-mediated glucose and fatty acid excursion.
15 November 2025 in Journal of Biological Chemistry
The mammalian microtubule-associated serine/threonine (MAST) kinases are a highly conserved subfamily of AGC kinases that are implicated as therapeutic targets for cancer and diabetes. However, the activity, regulation, and substrates of MAST kinases are poorly understood. We examined the biochemical activity of Mast2, as a representative of the MAST family. The domain of unknown function (DUF1908) is necessary for Mast2 kinase activity in vitro, while the PDZ domain is dispensable. Mast2 kinase activity does not appear to be compatible with the AGC kinase model of T-loop phospho-activation. Instead, it contains a unique insertion that is likely stabilized by ion-pair interactions. The C-terminus of the kinase domain contains motifs regulated by mTOR in other AGC kinases, and mutation of these conserved residues reduces Mast2 kinase activity. Consistent with mTOR regulation, Mast2 purified from insulin-stimulated cells has increased activity compared to serum-starved cells, and this increase in activity is dependent on mTOR. Finally, stable 18O-ATP labeled kinase assay linked phospho-proteomics (SIKALIP) identifies a collection of putative Mast2 substrates, including the PP2A inhibitor, endosuphine-α (ENSA). Our results develop a biochemical profile of the MAST Kinases, provide insight into their regulatory mechanisms, and begin to identify the cellular function of MAST2.
Metastatic dissemination of breast tumor cells to multiple sites of metastasis at early and late tumor endpoints in mice with or without dysbiosis, treated or untreated with colesevelam.